Specializing in cosmetic and pharmaceutical ingredients, this small-cap company develops and markets proprietary formulations including lubricants and antimicrobials. Investors monitor its niche position in specialty chemicals and consistent dividend payments despite limited revenue growth.
No congressional trades have been disclosed for United-Guardian, Inc. (UG) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.